Exact Mass: 576.4502

Exact Mass Matches: 576.4502

Found 500 metabolites which its exact mass value is equals to given mass value 576.4502, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

beta-Sitosterol 3-O-beta-D-galactopyranoside

(2R,3R,4S,5S,6R)-2-(((3S,8S,9S,10R,13R,14S,17R)-17-((2R,5R)-5-Ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

C35H60O6 (576.439)


Daucosterol is a steroid saponin that is sitosterol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has bee isolated from Panax japonicus var. major and Breynia fruticosa. It has a role as a plant metabolite. It is a steroid saponin, a beta-D-glucoside and a monosaccharide derivative. It is functionally related to a sitosterol. It derives from a hydride of a stigmastane. Sitogluside is a natural product found in Ophiopogon intermedius, Ophiopogon jaburan, and other organisms with data available. beta-Sitosterol 3-O-beta-D-galactopyranoside is found in herbs and spices. beta-Sitosterol 3-O-beta-D-galactopyranoside is a constituent of Hibiscus sabdariffa (roselle) leaves. C308 - Immunotherapeutic Agent Daucosterol is a natural sterol compound. Daucosterol is a natural sterol compound.

   

3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid

3-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-4-hydroxy-5-methoxybenzoic acid

C38H56O4 (576.4178)


3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid is an intermediate in the biosynthesis of Ubiquinone. It is a substrate for Hexaprenyldihydroxybenzoate methyltransferase (mitochondrial). [HMDB] 3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid is an intermediate in the biosynthesis of Ubiquinone. It is a substrate for Hexaprenyldihydroxybenzoate methyltransferase (mitochondrial).

   

2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone

4-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-5-hydroxy-6-methoxy-3-methylcyclohexa-3,5-diene-1,2-dione

C38H56O4 (576.4178)


2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is involved in the ubiquinone biosynthesis pathway. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is created from 2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone by ubiquinone biosynthesis monooxygenase Coq7 [EC:1.14.13.-]. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is then converted to ubiquinone by hexaprenyldihydroxybenzoate methyltransferase [EC:2.1.1.114]. [HMDB] 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is involved in the ubiquinone biosynthesis pathway. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is created from 2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone by ubiquinone biosynthesis monooxygenase Coq7 [EC:1.14.13.-]. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is then converted to ubiquinone by hexaprenyldihydroxybenzoate methyltransferase [EC:2.1.1.114].

   

Campesteryl ferulate

[17-(5,6-dimethylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (Z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178)


Campesteryl ferulate is found in cereals and cereal products. Campesteryl ferulate is a constituent of various cereal grains Constituent of various cereal grains

   

Schottenol 3-glucoside

2-{[14-(5-ethyl-6-methylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-9-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


Constituent of citron-melon fruits (Citrullus lanatus variety citroides). Schottenol 3-glucoside is found in watermelon, fruits, and spinach. Schottenol 3-glucoside is found in fruits. Schottenol 3-glucoside is a constituent of citron-melon fruits (Citrullus lanatus var. citroides).

   

DG(15:0/18:3(6Z,9Z,12Z)/0:0)

(2S)-1-hydroxy-3-(pentadecanoyloxy)propan-2-yl (6Z,9Z,12Z)-octadeca-6,9,12-trienoate

C36H64O5 (576.4753)


DG(15:0/18:3(6Z,9Z,12Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(15:0/18:3(6Z,9Z,12Z)/0:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of g-linolenic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the g-linolenic acid moiety is derived from animal fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

   

DG(15:0/18:3(9Z,12Z,15Z)/0:0)

(2S)-1-hydroxy-3-(pentadecanoyloxy)propan-2-yl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C36H64O5 (576.4753)


DG(15:0/18:3(9Z,12Z,15Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(15:0/18:3(9Z,12Z,15Z)/0:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of a-linolenic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position. DG(15:0/18:3(9Z,12Z,15Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(15:0/18:3(9Z,12Z,15Z)/0:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of a-linolenic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.

   

DG(18:3(6Z,9Z,12Z)/15:0/0:0)

(2S)-3-hydroxy-2-(pentadecanoyloxy)propyl (6Z,9Z,12Z)-octadeca-6,9,12-trienoate

C36H64O5 (576.4753)


DG(18:3(6Z,9Z,12Z)/15:0/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(18:3(6Z,9Z,12Z)/15:0/0:0), in particular, consists of one chain of g-linolenic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The g-linolenic acid moiety is derived from animal fats, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

   

DG(18:3(9Z,12Z,15Z)/15:0/0:0)

(2S)-3-hydroxy-2-(pentadecanoyloxy)propyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C36H64O5 (576.4753)


DG(18:3(9Z,12Z,15Z)/15:0/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(18:3(9Z,12Z,15Z)/15:0/0:0), in particular, consists of one chain of a-linolenic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position. DG(18:3(9Z,12Z,15Z)/15:0/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(18:3(9Z,12Z,15Z)/15:0/0:0), in particular, consists of one chain of a-linolenic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.

   

DG(15:0/0:0/18:3n6)

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (6Z,9Z,12Z)-octadeca-6,9,12-trienoic acid

C36H64O5 (576.4753)


DG(15:0/0:0/18:3n6) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1, C-2, or C-3 positions. DG(15:0/0:0/18:3n6), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of g-linolenic acid at the C-3 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the g-linolenic acid moiety is derived from animal fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.

   

DG(15:0/0:0/18:3n3)

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid

C36H64O5 (576.4753)


DG(15:0/0:0/18:3n3) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1, C-2, or C-3 positions. DG(15:0/0:0/18:3n3), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of a-linolenic acid at the C-3 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.

   

DG(14:1n5/0:0/18:2n6)

(2S)-2-Hydroxy-3-[(5Z)-tetradec-5-enoyloxy]propyl (9Z,12Z)-nonadeca-9,12-dienoic acid

C36H64O5 (576.4753)


DG(14:1n5/0:0/18:2n6) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1, C-2, or C-3 positions. DG(14:1n5/0:0/18:2n6), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of linoleic acid at the C-3 position. The myristoleic acid moiety is derived from milk fats, while the linoleic acid moiety is derived from seed oils. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.

   

DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.439)


DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propan-2-yl dodecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.439)


DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl dodecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl dodecanoic acid

C35H60O6 (576.439)


DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl dodecanoic acid

C35H60O6 (576.439)


DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl dodecanoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl dodecanoic acid

C35H60O6 (576.439)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5R,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0)

(2S)-3-(dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C35H60O6 (576.439)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propan-2-yl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 10-methylundecanoic acid

C35H60O6 (576.439)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5R,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-12:0)

(2S)-2-hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C35H60O6 (576.439)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(i-12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.439)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

24-Methylcholesterol ferulate

(2R,5S,14R,15R)-14-[(2R)-5,6-dimethylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178)


24-methylcholesterol ferulate is a member of the class of compounds known as steroid esters. Steroid esters are compounds containing a steroid moiety which bears a carboxylic acid ester group. 24-methylcholesterol ferulate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 24-methylcholesterol ferulate can be found in corn, which makes 24-methylcholesterol ferulate a potential biomarker for the consumption of this food product.

   

24-Methyllathosterol ferulate

(2S,5S,7S,14R,15R)-14-[(2R)-5,6-dimethylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-9-en-5-yl (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178)


24-methyllathosterol ferulate is a member of the class of compounds known as steroid esters. Steroid esters are compounds containing a steroid moiety which bears a carboxylic acid ester group. 24-methyllathosterol ferulate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 24-methyllathosterol ferulate can be found in corn, which makes 24-methyllathosterol ferulate a potential biomarker for the consumption of this food product.

   

24-Methylenecholestanol ferulate

(2S,5S,7S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methyl-5-methylideneheptan-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178)


24-methylenecholestanol ferulate is a member of the class of compounds known as steroid esters. Steroid esters are compounds containing a steroid moiety which bears a carboxylic acid ester group. 24-methylenecholestanol ferulate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 24-methylenecholestanol ferulate can be found in corn, which makes 24-methylenecholestanol ferulate a potential biomarker for the consumption of this food product.

   

Coriandrinol

(2R,3R,4S,5S,6R)-2-{[(1S,2R,10S,11S,15R)-14-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


Coriandrinol belongs to stigmastanes and derivatives class of compounds. Those are sterol lipids with a structure based on the stigmastane skeleton, which consists of a cholestane moiety bearing an ethyl group at the carbon atom C24. Coriandrinol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Coriandrinol can be found in coriander, which makes coriandrinol a potential biomarker for the consumption of this food product. Daucosterol is a natural sterol compound. Daucosterol is a natural sterol compound.

   

Bacosterol-3-O-beta-D-glucopyranoside

Bacosterol-3-O-beta-D-glucopyranoside

C35H60O6 (576.439)


   

beta-Sitosteryl-D-glucoside

beta-Sitosteryl-D-glucoside

C35H60O6 (576.439)


   

beta-sitosterol-delta-glucopyranoside|beta-sitosteryl-beta-D-glucoside|sitosterol-beta-D-glucoside

beta-sitosterol-delta-glucopyranoside|beta-sitosteryl-beta-D-glucoside|sitosterol-beta-D-glucoside

C35H60O6 (576.439)


   

sitosterol-3beta-glucopyranoside

sitosterol-3beta-glucopyranoside

C35H60O6 (576.439)


   

SCHEMBL11913139

SCHEMBL11913139

C35H60O6 (576.439)


   

putative heterocyst glycolipid

putative heterocyst glycolipid

C32H64O8 (576.4601)


   

3alpha-hydroxy-28beta-methoxy-13alpha-ursan-28,12beta-epoxide 3-benzoate

3alpha-hydroxy-28beta-methoxy-13alpha-ursan-28,12beta-epoxide 3-benzoate

C38H56O4 (576.4178)


   

beta-sitosterol beta-D-glucopyranoside

beta-sitosterol beta-D-glucopyranoside

C35H60O6 (576.439)


   

beta-sitosterol-3-O-beta-D-glucopyranoside

beta-sitosterol-3-O-beta-D-glucopyranoside

C35H60O6 (576.439)


   

beta-sitosterol-3-O-beta-D-glucoside

beta-sitosterol-3-O-beta-D-glucoside

C35H60O6 (576.439)


   

Daucosterol

(2R,3R,4S,5S,6R)-2-(((3S,8S,9S,10R,13R,14S,17R)-17-((2R,5R)-5-Ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

C35H60O6 (576.439)


Daucosterol is a steroid saponin that is sitosterol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has bee isolated from Panax japonicus var. major and Breynia fruticosa. It has a role as a plant metabolite. It is a steroid saponin, a beta-D-glucoside and a monosaccharide derivative. It is functionally related to a sitosterol. It derives from a hydride of a stigmastane. Sitogluside is a natural product found in Ophiopogon intermedius, Ophiopogon jaburan, and other organisms with data available. A steroid saponin that is sitosterol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has bee isolated from Panax japonicus var. major and Breynia fruticosa. C308 - Immunotherapeutic Agent Daucosterol is a natural sterol compound. Daucosterol is a natural sterol compound.

   

10,10-Methylenebis(norvallesamidine)

10,10-Methylenebis(norvallesamidine)

C39H52N4 (576.4192)


   

beta-sitosterol-beta-D-glucoside

beta-sitosterol-beta-D-glucoside

C35H60O6 (576.439)


   

beta-Sitosterylglucosid

beta-Sitosterylglucosid

C35H60O6 (576.439)


   

(2??, 22?鈥? 31S, 32R, 33S, 34R)-form-2-Methyl-29-(1, 2, 3, 4, 5-pentahydroxypentyl)hopane

(2??, 22?鈥? 31S, 32R, 33S, 34R)-form-2-Methyl-29-(1, 2, 3, 4, 5-pentahydroxypentyl)hopane

C36H64O5 (576.4753)


   

beta-sitosterol-beta-D-glucoside|stigmast-6-en-3-O-beta-(D-glucopyranoside)

beta-sitosterol-beta-D-glucoside|stigmast-6-en-3-O-beta-(D-glucopyranoside)

C35H60O6 (576.439)


   

5-(1-Phytoxy-ethyl)-2-hydroxy-7-methoxy-1,8-dimethyl-9,10-dihydrophenanthrene

5-(1-Phytoxy-ethyl)-2-hydroxy-7-methoxy-1,8-dimethyl-9,10-dihydrophenanthrene

C39H60O3 (576.4542)


   

geniculatoside F|stigmast-16-en-3alpha-O-(beta-D-galactopyranoside)

geniculatoside F|stigmast-16-en-3alpha-O-(beta-D-galactopyranoside)

C35H60O6 (576.439)


   

24-methylenecholestanol ferulate

24-methylenecholestanol ferulate

C38H56O4 (576.4178)


   

(24R,S)-24-methyllathosterol ferulate

(24R,S)-24-methyllathosterol ferulate

C38H56O4 (576.4178)


   

Dereplicator Identification - triol_glucoside

Dereplicator Identification - triol_glucoside

C32H64O8 (576.4601)


   

DG(16:1/17:2/0:0)[iso2]

1-(9Z-hexadecenoyl)-2-(9Z,12Z-heptadecadienoyl)-sn-glycerol

C36H64O5 (576.4753)


   

1-(O-alpha-D-glucopyranosyl)-(1,3R,25R)-hexacosanetriol

1-(O-alpha-D-glucopyranosyl)-(1,3R,25R)-hexacosanetriol

C32H64O8 (576.4601)


   

1-(O-alpha-D-glucopyranosyl)-(1,3S,25R)-hexacosanetriol

1-(O-alpha-D-glucopyranosyl)-(1,3S,25R)-hexacosanetriol

C32H64O8 (576.4601)


   

Diglyceride

1-alpha-Linolenoyl-2-pentadecanoyl-sn-glycerol

C36H64O5 (576.4753)


   

stigmast-5-en-3beta-ol 3-0-beta-D-glucopyranoside

stigmast-5-en-3beta-ol 3-0-beta-D-glucopyranoside

C35H60O6 (576.439)


   

beta-Sitosterol 3-O-beta-D-galactopyranoside

2-{[14-(5-ethyl-6-methylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

Schottenol glucoside

2-{[14-(5-ethyl-6-methylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-9-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

Campesteryl ferulate

14-(5,6-dimethylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (2Z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178)


   

DG(13:0/20:3(8Z,11Z,14Z)/0:0)[iso2]

1-tridecanoyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycerol

C36H64O5 (576.4753)


   

DG(15:1(9Z)/18:2(9Z,12Z)/0:0)[iso2]

1-(9Z-pentadecenoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycerol

C36H64O5 (576.4753)


   

DG 33:3

1-(9Z-pentadecenoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycerol

C36H64O5 (576.4753)


   

glucoclionasterol

poriferast-5-en-3beta-yl beta-D-glucopyranoside

C35H60O6 (576.439)


   

ST 29:1;O;Hex

stigmast-5-en-3beta-yl beta-D-galactopyranoside

C35H60O6 (576.439)


   

Oryzanol

campest-5-en-3beta-yl ferulate

C38H56O4 (576.4178)


   

3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid

3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid

C38H56O4 (576.4178)


   
   

1-[3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy]hexacosane-3,25-diol

1-[3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy]hexacosane-3,25-diol

C32H64O8 (576.4601)


   

Sitosterol glucoside

3-O-(beta-D-glucopyranosyl)-stigmast-5-en-3beta-ol

C35H60O6 (576.439)


   

24-Methyllathosterol ferulate

24-Methyllathosterol ferulate

C38H56O4 (576.4178)


   

[(3S,10R,13R,17R)-17-[(2R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

[(3S,10R,13R,17R)-17-[(2R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178)


   

DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C35H60O6 (576.439)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C35H60O6 (576.439)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C35H60O6 (576.439)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C35H60O6 (576.439)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C35H60O6 (576.439)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C35H60O6 (576.439)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0)

C35H60O6 (576.439)


   

DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0)

C35H60O6 (576.439)


   

DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C35H60O6 (576.439)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C35H60O6 (576.439)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C35H60O6 (576.439)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C35H60O6 (576.439)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C35H60O6 (576.439)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C35H60O6 (576.439)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C35H60O6 (576.439)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

DG(i-12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C35H60O6 (576.439)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-12:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

DG(i-12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C35H60O6 (576.439)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-12:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-12:0)

C35H60O6 (576.439)


   

DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C35H60O6 (576.439)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0)

C35H60O6 (576.439)


   

DG(i-12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

DG(i-12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C35H60O6 (576.439)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-12:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-12:0)

C35H60O6 (576.439)


   

C35 phosphodolichol

C35 phosphodolichol

C35H61O4P (576.4307)


   

Dereplicator Identification-triol_glucoside

Dereplicator Identification-triol_glucoside

C32H64O8 (576.4601)


   

NAOrn 13:0/16:3

NAOrn 13:0/16:3

C34H60N2O5 (576.4502)


   

NAOrn 11:0/18:3

NAOrn 11:0/18:3

C34H60N2O5 (576.4502)


   

NAOrn 16:3/13:0

NAOrn 16:3/13:0

C34H60N2O5 (576.4502)


   

NAOrn 13:1/16:2

NAOrn 13:1/16:2

C34H60N2O5 (576.4502)


   

NAOrn 16:2/13:1

NAOrn 16:2/13:1

C34H60N2O5 (576.4502)


   

NAOrn 18:3/11:0

NAOrn 18:3/11:0

C34H60N2O5 (576.4502)


   

Mgdg O-19:0_3:0

Mgdg O-19:0_3:0

C31H60O9 (576.4237)


   

Mgdg O-9:0_13:0

Mgdg O-9:0_13:0

C31H60O9 (576.4237)


   

Mgdg O-14:0_8:0

Mgdg O-14:0_8:0

C31H60O9 (576.4237)


   

Mgdg O-18:0_4:0

Mgdg O-18:0_4:0

C31H60O9 (576.4237)


   

Mgdg O-8:0_14:0

Mgdg O-8:0_14:0

C31H60O9 (576.4237)


   

Mgdg O-13:0_9:0

Mgdg O-13:0_9:0

C31H60O9 (576.4237)


   

Mgdg O-16:0_6:0

Mgdg O-16:0_6:0

C31H60O9 (576.4237)


   

Mgdg O-17:0_5:0

Mgdg O-17:0_5:0

C31H60O9 (576.4237)


   

Mgdg O-20:0_2:0

Mgdg O-20:0_2:0

C31H60O9 (576.4237)


   

Mgdg O-15:0_7:0

Mgdg O-15:0_7:0

C31H60O9 (576.4237)


   

Mgdg O-12:0_10:0

Mgdg O-12:0_10:0

C31H60O9 (576.4237)


   

Mgdg O-11:0_11:0

Mgdg O-11:0_11:0

C31H60O9 (576.4237)


   

Mgdg O-10:0_12:0

Mgdg O-10:0_12:0

C31H60O9 (576.4237)


   

PE-Cer 14:1;2O/14:0

PE-Cer 14:1;2O/14:0

C30H61N2O6P (576.4267)


   

PE-Cer 13:1;2O/15:0

PE-Cer 13:1;2O/15:0

C30H61N2O6P (576.4267)


   

PE-Cer 12:1;2O/16:0

PE-Cer 12:1;2O/16:0

C30H61N2O6P (576.4267)


   

PE-Cer 15:1;2O/13:0

PE-Cer 15:1;2O/13:0

C30H61N2O6P (576.4267)


   

PE-Cer 13:0;2O/15:1

PE-Cer 13:0;2O/15:1

C30H61N2O6P (576.4267)


   

PE-Cer 15:0;2O/13:1

PE-Cer 15:0;2O/13:1

C30H61N2O6P (576.4267)


   

PE-Cer 16:1;2O/12:0

PE-Cer 16:1;2O/12:0

C30H61N2O6P (576.4267)


   

PE-Cer 14:0;2O/14:1

PE-Cer 14:0;2O/14:1

C30H61N2O6P (576.4267)


   

PE-Cer 12:0;2O/16:1

PE-Cer 12:0;2O/16:1

C30H61N2O6P (576.4267)


   

[(E)-2-acetamido-3-hydroxytricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-acetamido-3-hydroxytricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[(E)-2-(butanoylamino)-3-hydroxyhenicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(butanoylamino)-3-hydroxyhenicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[(E)-3-hydroxy-2-(nonanoylamino)hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(nonanoylamino)hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[(E)-2-(hexadecanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(hexadecanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[(E)-2-(heptadecanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(heptadecanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[(E)-3-hydroxy-2-(pentanoylamino)icos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(pentanoylamino)icos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[(E)-2-(hexanoylamino)-3-hydroxynonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(hexanoylamino)-3-hydroxynonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[(E)-2-(heptanoylamino)-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(heptanoylamino)-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[(E)-3-hydroxy-2-(octanoylamino)heptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(octanoylamino)heptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[(E)-3-hydroxy-2-(propanoylamino)docos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(propanoylamino)docos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[(E)-2-(decanoylamino)-3-hydroxypentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(decanoylamino)-3-hydroxypentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[(E)-3-hydroxy-2-(undecanoylamino)tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(undecanoylamino)tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[(E)-3-hydroxy-2-(pentadecanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(pentadecanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[(E)-3-hydroxy-2-(tridecanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(tridecanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[(E)-2-(dodecanoylamino)-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(dodecanoylamino)-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]undecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]undecyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[(E)-3-hydroxy-2-(tetradecanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(tetradecanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

2,3-di(octanoyloxy)propyl (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

2,3-di(octanoyloxy)propyl (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C35H60O6 (576.439)


   

Fahfa 16:4/22:5

Fahfa 16:4/22:5

C38H56O4 (576.4178)


   

Fahfa 22:6/16:3

Fahfa 22:6/16:3

C38H56O4 (576.4178)


   

Fahfa 18:5/20:4

Fahfa 18:5/20:4

C38H56O4 (576.4178)


   

[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-hydroxypropyl] heptadecanoate

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-hydroxypropyl] heptadecanoate

C36H64O5 (576.4753)


   

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C36H64O5 (576.4753)


   

[1-hydroxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

[1-hydroxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C36H64O5 (576.4753)


   

(1-hydroxy-3-undecanoyloxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate

(1-hydroxy-3-undecanoyloxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C36H64O5 (576.4753)


   

[1-[(Z)-hexadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

[1-[(Z)-hexadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C36H64O5 (576.4753)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hydroxypropyl] (Z)-heptadec-9-enoate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hydroxypropyl] (Z)-heptadec-9-enoate

C36H64O5 (576.4753)


   

(1-hydroxy-3-pentadecanoyloxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

(1-hydroxy-3-pentadecanoyloxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C36H64O5 (576.4753)


   

(1-hydroxy-3-tridecanoyloxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate

(1-hydroxy-3-tridecanoyloxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C36H64O5 (576.4753)


   

[1-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

[1-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C36H64O5 (576.4753)


   

(1-hydroxy-3-nonanoyloxypropan-2-yl) (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

(1-hydroxy-3-nonanoyloxypropan-2-yl) (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

C36H64O5 (576.4753)


   

N-(decanoyl)-4E-pentadecasphingenine-1-phosphocholine

N-(decanoyl)-4E-pentadecasphingenine-1-phosphocholine

C30H61N2O6P (576.4267)


   

[(2S)-3-hydroxy-2-tridecanoyloxypropyl] (8E,11E,14E)-icosa-8,11,14-trienoate

[(2S)-3-hydroxy-2-tridecanoyloxypropyl] (8E,11E,14E)-icosa-8,11,14-trienoate

C36H64O5 (576.4753)


   

[(E,2S,3R)-2-(decanoylamino)-3-hydroxypentadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E,2S,3R)-2-(decanoylamino)-3-hydroxypentadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)


   

[1-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-hydroxypropan-2-yl] (E)-heptadec-7-enoate

[1-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-hydroxypropan-2-yl] (E)-heptadec-7-enoate

C36H64O5 (576.4753)


   

[(2S)-1-hydroxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate

[(2S)-1-hydroxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate

C36H64O5 (576.4753)


   

[1-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-hydroxypropan-2-yl] heptadecanoate

[1-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-hydroxypropan-2-yl] heptadecanoate

C36H64O5 (576.4753)


   

[(2S)-3-hydroxy-2-pentadecanoyloxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

[(2S)-3-hydroxy-2-pentadecanoyloxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C36H64O5 (576.4753)


   

[(2S)-2-[(E)-hexadec-9-enoyl]oxy-3-hydroxypropyl] (9E,12E)-heptadeca-9,12-dienoate

[(2S)-2-[(E)-hexadec-9-enoyl]oxy-3-hydroxypropyl] (9E,12E)-heptadeca-9,12-dienoate

C36H64O5 (576.4753)


   

[(2S)-1-hydroxy-3-tridecanoyloxypropan-2-yl] (8E,11E,14E)-icosa-8,11,14-trienoate

[(2S)-1-hydroxy-3-tridecanoyloxypropan-2-yl] (8E,11E,14E)-icosa-8,11,14-trienoate

C36H64O5 (576.4753)


   

[(2S)-1-[(E)-hexadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

[(2S)-1-[(E)-hexadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

C36H64O5 (576.4753)


   

[(2S)-3-hydroxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (9E,12E)-octadeca-9,12-dienoate

[(2S)-3-hydroxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (9E,12E)-octadeca-9,12-dienoate

C36H64O5 (576.4753)


   

[(2S)-1-hydroxy-3-pentadecanoyloxypropan-2-yl] (9E,12E,15E)-octadeca-9,12,15-trienoate

[(2S)-1-hydroxy-3-pentadecanoyloxypropan-2-yl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C36H64O5 (576.4753)


   

[1-carboxy-3-[2-hydroxy-3-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-hydroxy-3-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO6+ (576.4264)


   

3-demethylubiquinone-6

2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone

C38H56O4 (576.4178)


A polyprenylbenzoquinone that is fumigatin which is substituted by an all-trans-hexaprenyl group at position 6.

   

DG(15:0/18:3(9Z,12Z,15Z)/0:0)

DG(15:0/18:3(9Z,12Z,15Z)/0:0)

C36H64O5 (576.4753)


   

DG(15:0/18:3(6Z,9Z,12Z)/0:0)

DG(15:0/18:3(6Z,9Z,12Z)/0:0)

C36H64O5 (576.4753)


   

DG(18:3(6Z,9Z,12Z)/15:0/0:0)

DG(18:3(6Z,9Z,12Z)/15:0/0:0)

C36H64O5 (576.4753)


   

DG(18:3(9Z,12Z,15Z)/15:0/0:0)

DG(18:3(9Z,12Z,15Z)/15:0/0:0)

C36H64O5 (576.4753)


   

1-Pentadecanoyl-3-a-linolenoyl-sn-glycerol

1-Pentadecanoyl-3-a-linolenoyl-sn-glycerol

C36H64O5 (576.4753)


   

Sitosteryl glucoside

Sitosteryl glucoside

C35H60O6 (576.439)


   

C35-phosphodolichol

C35-phosphodolichol

C35H61O4P (576.4307)


A dolichyl phosphate in which the dolichyl moiety contains six prenyl units

   

diacylglycerol 33:3

diacylglycerol 33:3

C36H64O5 (576.4753)


A diglyceride in which the two acyl groups contain a total of 33 carbons and 3 double bonds.

   

TG(33:3)

TG(12:0(1)_10:2_11:1)

C36H64O5 (576.4753)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(32:3)

TG(16:0_6:0_10:3)

C35H60O6 (576.439)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

FAHFA 12:2/O-26:7

FAHFA 12:2/O-26:7

C38H56O4 (576.4178)


   

FAHFA 12:3/O-26:6

FAHFA 12:3/O-26:6

C38H56O4 (576.4178)


   

FAHFA 12:4/O-26:5

FAHFA 12:4/O-26:5

C38H56O4 (576.4178)


   

FAHFA 13:2/O-25:7

FAHFA 13:2/O-25:7

C38H56O4 (576.4178)


   

FAHFA 13:3/O-25:6

FAHFA 13:3/O-25:6

C38H56O4 (576.4178)


   

FAHFA 13:4/O-25:5

FAHFA 13:4/O-25:5

C38H56O4 (576.4178)


   

FAHFA 14:2/O-24:7

FAHFA 14:2/O-24:7

C38H56O4 (576.4178)


   

FAHFA 14:3/O-24:6

FAHFA 14:3/O-24:6

C38H56O4 (576.4178)


   

FAHFA 14:4/O-24:5

FAHFA 14:4/O-24:5

C38H56O4 (576.4178)


   

FAHFA 15:2/O-23:7

FAHFA 15:2/O-23:7

C38H56O4 (576.4178)


   

FAHFA 15:3/O-23:6

FAHFA 15:3/O-23:6

C38H56O4 (576.4178)


   

FAHFA 15:4/O-23:5

FAHFA 15:4/O-23:5

C38H56O4 (576.4178)


   

FAHFA 15:5/O-23:4

FAHFA 15:5/O-23:4

C38H56O4 (576.4178)


   

FAHFA 16:2/O-22:7

FAHFA 16:2/O-22:7

C38H56O4 (576.4178)


   

FAHFA 16:3/O-22:6

FAHFA 16:3/O-22:6

C38H56O4 (576.4178)


   

FAHFA 16:4/O-22:5

FAHFA 16:4/O-22:5

C38H56O4 (576.4178)


   

FAHFA 16:5/O-22:4

FAHFA 16:5/O-22:4

C38H56O4 (576.4178)


   

FAHFA 17:2/O-21:7

FAHFA 17:2/O-21:7

C38H56O4 (576.4178)


   

FAHFA 17:3/O-21:6

FAHFA 17:3/O-21:6

C38H56O4 (576.4178)


   

FAHFA 17:4/O-21:5

FAHFA 17:4/O-21:5

C38H56O4 (576.4178)


   

FAHFA 17:5/O-21:4

FAHFA 17:5/O-21:4

C38H56O4 (576.4178)


   

FAHFA 18:3/O-20:6

FAHFA 18:3/O-20:6

C38H56O4 (576.4178)


   

FAHFA 18:4/O-20:5

FAHFA 18:4/O-20:5

C38H56O4 (576.4178)


   

FAHFA 18:5/O-20:4

FAHFA 18:5/O-20:4

C38H56O4 (576.4178)


   

FAHFA 18:6/O-20:3

FAHFA 18:6/O-20:3

C38H56O4 (576.4178)


   

FAHFA 19:3/O-19:6

FAHFA 19:3/O-19:6

C38H56O4 (576.4178)


   

FAHFA 19:4/O-19:5

FAHFA 19:4/O-19:5

C38H56O4 (576.4178)


   

FAHFA 19:5/O-19:4

FAHFA 19:5/O-19:4

C38H56O4 (576.4178)


   

FAHFA 19:6/O-19:3

FAHFA 19:6/O-19:3

C38H56O4 (576.4178)


   

FAHFA 20:3/O-18:6

FAHFA 20:3/O-18:6

C38H56O4 (576.4178)


   

FAHFA 20:4/O-18:5

FAHFA 20:4/O-18:5

C38H56O4 (576.4178)


   

FAHFA 20:5/O-18:4

FAHFA 20:5/O-18:4

C38H56O4 (576.4178)


   

FAHFA 20:6/O-18:3

FAHFA 20:6/O-18:3

C38H56O4 (576.4178)


   

FAHFA 21:4/O-17:5

FAHFA 21:4/O-17:5

C38H56O4 (576.4178)


   

FAHFA 21:5/O-17:4

FAHFA 21:5/O-17:4

C38H56O4 (576.4178)


   

FAHFA 21:6/O-17:3

FAHFA 21:6/O-17:3

C38H56O4 (576.4178)


   

FAHFA 21:7/O-17:2

FAHFA 21:7/O-17:2

C38H56O4 (576.4178)


   

FAHFA 22:4/O-16:5

FAHFA 22:4/O-16:5

C38H56O4 (576.4178)


   

FAHFA 22:5/O-16:4

FAHFA 22:5/O-16:4

C38H56O4 (576.4178)


   

FAHFA 22:6/O-16:3

FAHFA 22:6/O-16:3

C38H56O4 (576.4178)


   

FAHFA 22:7/O-16:2

FAHFA 22:7/O-16:2

C38H56O4 (576.4178)


   

FAHFA 23:4/O-15:5

FAHFA 23:4/O-15:5

C38H56O4 (576.4178)


   

FAHFA 23:5/O-15:4

FAHFA 23:5/O-15:4

C38H56O4 (576.4178)


   

FAHFA 23:6/O-15:3

FAHFA 23:6/O-15:3

C38H56O4 (576.4178)


   

FAHFA 23:7/O-15:2

FAHFA 23:7/O-15:2

C38H56O4 (576.4178)


   

FAHFA 24:5/O-14:4

FAHFA 24:5/O-14:4

C38H56O4 (576.4178)


   

FAHFA 24:6/O-14:3

FAHFA 24:6/O-14:3

C38H56O4 (576.4178)


   

FAHFA 24:7/O-14:2

FAHFA 24:7/O-14:2

C38H56O4 (576.4178)


   

FAHFA 25:5/O-13:4

FAHFA 25:5/O-13:4

C38H56O4 (576.4178)


   

FAHFA 25:6/O-13:3

FAHFA 25:6/O-13:3

C38H56O4 (576.4178)


   

FAHFA 25:7/O-13:2

FAHFA 25:7/O-13:2

C38H56O4 (576.4178)


   

FAHFA 26:5/O-12:4

FAHFA 26:5/O-12:4

C38H56O4 (576.4178)


   

FAHFA 26:6/O-12:3

FAHFA 26:6/O-12:3

C38H56O4 (576.4178)


   

FAHFA 26:7/O-12:2

FAHFA 26:7/O-12:2

C38H56O4 (576.4178)


   

FAHFA 38:9;O

FAHFA 38:9;O

C38H56O4 (576.4178)


   

DG 13:0_20:3

DG 13:0_20:3

C36H64O5 (576.4753)


   

DG 15:0_18:3

DG 15:0_18:3

C36H64O5 (576.4753)


   

DG 15:1_18:2

DG 15:1_18:2

C36H64O5 (576.4753)


   

DG 16:1_17:2

DG 16:1_17:2

C36H64O5 (576.4753)


   

MGDG O-22:0

MGDG O-22:0

C31H60O9 (576.4237)


   
   

Hexaprenylmethylhydroxymethoxybenzoquinone

Hexaprenylmethylhydroxymethoxybenzoquinone

C38H56O4 (576.4178)


   

CerPE 14:0;O2/14:1

CerPE 14:0;O2/14:1

C30H61N2O6P (576.4267)


   

CerPE 14:1;O2/14:0

CerPE 14:1;O2/14:0

C30H61N2O6P (576.4267)


   

CerPE 15:1;O2/13:0

CerPE 15:1;O2/13:0

C30H61N2O6P (576.4267)


   

CerPE 16:1;O2/12:0

CerPE 16:1;O2/12:0

C30H61N2O6P (576.4267)


   

CerPE 17:1;O2/11:0

CerPE 17:1;O2/11:0

C30H61N2O6P (576.4267)


   

CerPE 18:1;O2/10:0

CerPE 18:1;O2/10:0

C30H61N2O6P (576.4267)


   
   
   
   
   
   

(2s,3r,4s,5s,6r)-2-{[(3s,25s)-3,25-dihydroxyhexacosyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(3s,25s)-3,25-dihydroxyhexacosyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C32H64O8 (576.4601)


   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-3b,9a-dimethyl-1h,2h,3h,3ah,4h,6h,7h,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-3b,9a-dimethyl-1h,2h,3h,3ah,4h,6h,7h,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(1r,4as,5s)-5-[(1r,6s)-6-[(2e)-4-[(1s,5r,8ar)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]but-2-en-2-yl]-2-methylcyclohex-2-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

(1r,4as,5s)-5-[(1r,6s)-6-[(2e)-4-[(1s,5r,8ar)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]but-2-en-2-yl]-2-methylcyclohex-2-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C39H60O3 (576.4542)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2s,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2s,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5r,6r)-4-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

(2r,3r,4s,5r,6r)-4-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

C35H60O6 (576.439)


   

(2s,3r,4s,5s,6r)-2-{[(3r,25r)-3,25-dihydroxyhexacosyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(3r,25r)-3,25-dihydroxyhexacosyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C32H64O8 (576.4601)


   

(2s,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2s,3s,4r,5r,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3s,4r,5r,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3s,4r,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3s,4r,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2s,3r,4s,5s,6r)-2-{[(3s,25r)-3,25-dihydroxyhexacosyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(3s,25r)-3,25-dihydroxyhexacosyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C32H64O8 (576.4601)


   

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

5-(1-phytoxy-ethyl)-2-hydroxy-7-methoxy-1,8-dimethyl-9,10-dihydrophenanthrene

NA

C39H60O3 (576.4542)


{"Ingredient_id": "HBIN010966","Ingredient_name": "5-(1-phytoxy-ethyl)-2-hydroxy-7-methoxy-1,8-dimethyl-9,10-dihydrophenanthrene","Alias": "NA","Ingredient_formula": "C39H60O3","Ingredient_Smile": "CC1=C(C=CC2=C1CCC3=C2C(=CC(=C3C)OC)C(C)OCC=C(C)CCCC(C)CCCC(C)CCCC(C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "17260","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

6′-palmitoxyl-β-daucosterin

NA

C35H60O6 (576.439)


{"Ingredient_id": "HBIN012746","Ingredient_name": "6\u2032-palmitoxyl-\u03b2-daucosterin","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "33331","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

aucosterol

NA

C35H60O6 (576.439)


{"Ingredient_id": "HBIN017340","Ingredient_name": "aucosterol","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "33332","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

bacosterol-3-o-β-d-glucopyranoside

NA

C35H60O6 (576.439)


{"Ingredient_id": "HBIN017504","Ingredient_name": "bacosterol-3-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CC=CC2CCC3CC(CCC3(C2=CCC1C)C)OC4C(C(C(C(O4)CO)O)O)O)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2095","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

β-daucosterin

NA

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018050","Ingredient_name": "\u03b2-daucosterin","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35374","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

β-daucostero

NA

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018051","Ingredient_name": "\u03b2-daucostero","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "39817","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

β-dauosterol

NA

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018054","Ingredient_name": "\u03b2-dauosterol","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "36019","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

β-sitosterol-3-o-β-d-glucoside

β-sitosterol-3-o-β-d-gluco-side; beta-sitosterol-3-o-beta-d-gluco-side; beta-sitosterol-3-o-beta-d-glucoside

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018290","Ingredient_name": "\u03b2-sitosterol-3-o-\u03b2-d-glucoside","Alias": "\u03b2-sitosterol-3-o-\u03b2-d-gluco-side; beta-sitosterol-3-o-beta-d-gluco-side; beta-sitosterol-3-o-beta-d-glucoside","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "576.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT01935","TCMID_id": "19969;23905;25113","TCMSP_id": "NA","TCM_ID_id": "10347;10348;6243","PubChem_id": "12309073","DrugBank_id": "NA"}

   

β-sitosterol-α-d-glucoside

NA

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018296","Ingredient_name": "\u03b2-sitosterol-\u03b1-d-glucoside","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "19970","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

beta-Sitosterol-alpha-glucoside

beta-sitosterol-alpha-glucoside; β-sitosterol-α- glucoside

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018297","Ingredient_name": "beta-Sitosterol-alpha-glucoside","Alias": "beta-sitosterol-alpha-glucoside; \u03b2-sitosterol-\u03b1- glucoside","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "576.95","OB_score": "20.63193686","CAS_id": "NA","SymMap_id": "SMIT01014","TCMID_id": "25282;34477","TCMSP_id": "MOL001770","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

beta-sitosterol-beta-d-glucoside

β- sitosterol-β-D- glucoside; β-sitosterol-β-D-glucoside; β-sitosterol-β-d-glucoside; β-sitosterol- β- D- glucoside

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018301","Ingredient_name": "beta-sitosterol-beta-d-glucoside","Alias": "\u03b2- sitosterol-\u03b2-D- glucoside; \u03b2-sitosterol-\u03b2-D-glucoside; \u03b2-sitosterol-\u03b2-d-glucoside; \u03b2-sitosterol- \u03b2- D- glucoside","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "576.8 g/mol","OB_score": "19.57852635","CAS_id": "NA","SymMap_id": "SMIT08823;SMIT17727","TCMID_id": "25281;41224;35764;19971;38323","TCMSP_id": "MOL007375","TCM_ID_id": "17880","PubChem_id": "91884650","DrugBank_id": "NA"}

   

β-sitosterol- D- glucoside

beta-sitosterol-d-glucoside

C35H60O6 (576.439)


{"Ingredient_id": "HBIN018304","Ingredient_name": "\u03b2-sitosterol- D- glucoside","Alias": "beta-sitosterol-d-glucoside","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "576.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35368","TCMSP_id": "NA","TCM_ID_id": "19707;21899","PubChem_id": "12309060","DrugBank_id": "NA"}

   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-3a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-3a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7r,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7r,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6as,10r,11s,13bs)-10-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6as,10r,11s,13bs)-10-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(3s,4as,6as,10r,11s,13bs)-10-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3s,4as,6as,10r,11s,13bs)-10-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

2-{[10-(5-ethyl-6-methylheptan-2-yl)-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[10-(5-ethyl-6-methylheptan-2-yl)-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-methoxyoxane-3,4,5-triol

(2r,3r,4s,5s,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-methoxyoxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3br,7s,9as,9br,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-3a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3br,7s,9as,9br,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-3a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-methoxyoxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-methoxyoxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-3b,9a-dimethyl-1h,2h,3h,3ah,4h,6h,7h,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-3b,9a-dimethyl-1h,2h,3h,3ah,4h,6h,7h,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2s,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5as,7s,9as,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5as,7s,9as,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4r,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4r,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3r,4s,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

7-methoxy-1,8-dimethyl-5-[(1r)-1-{[(2e,7r,11r)-3,7,11,15-tetramethylhexadec-2-en-1-yl]oxy}ethyl]-9,10-dihydrophenanthren-2-ol

7-methoxy-1,8-dimethyl-5-[(1r)-1-{[(2e,7r,11r)-3,7,11,15-tetramethylhexadec-2-en-1-yl]oxy}ethyl]-9,10-dihydrophenanthren-2-ol

C39H60O3 (576.4542)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,5ar,7s,9as,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,5ar,7s,9as,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

7-methoxy-1,8-dimethyl-5-{1-[(3,7,11,15-tetramethylhexadec-2-en-1-yl)oxy]ethyl}-9,10-dihydrophenanthren-2-ol

7-methoxy-1,8-dimethyl-5-{1-[(3,7,11,15-tetramethylhexadec-2-en-1-yl)oxy]ethyl}-9,10-dihydrophenanthren-2-ol

C39H60O3 (576.4542)


   

(2r,3r,4s,5s,6r)-2-{[(3as,3bs,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3as,3bs,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

(2r,3s,4s,5s,6s)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3s,4s,5s,6s)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

2-{[(1r,7s,9ar,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[(1r,7s,9ar,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

4-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

4-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

C35H60O6 (576.439)


   

2-[(3,25-dihydroxyhexacosyl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(3,25-dihydroxyhexacosyl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C32H64O8 (576.4601)


   

(2s,3s,4r,5r,6s)-2-{[(1s,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3s,4r,5r,6s)-2-{[(1s,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)


   

2-{[(3r,25r)-3,25-dihydroxyhexacosyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[(3r,25r)-3,25-dihydroxyhexacosyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C32H64O8 (576.4601)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.439)